Clozapine Treatment in Very Early Onset Schizophrenia

TAMAR MOZES, PAZ TOREN, NADEJDA CHERNAUZAN, ROBERTO MESTER, RONI YORAN-HEGESH, RACHEL BLUMENSOHN, ABRAHAM WEIZMAN

Research output: Contribution to journalArticlepeer-review

Abstract

Very early onset schizophrenic patients only partially benefit from conventional antipsychotic treatment and are at increased risk for developing tardive dyskinesia (TD). Clozapine, which lacks extrapyramidal side effects including TD, has been proved effective for adult schizophrenic patients who are resistant to other neuroleptics. Clozapine, therefore, may offer an alternative treatment for these patients. The authors report four successful trials of clozapine in children aged 10 to 12 years old with schizophrenia, the youngest group reported on to date, who were unresponsive to conventional neuroleptic treatment.

Original languageEnglish
Pages (from-to)65-70
Number of pages6
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume33
Issue number1
DOIs
StatePublished - 1994

Keywords

  • children
  • clozapine
  • schizophrenia

Fingerprint

Dive into the research topics of 'Clozapine Treatment in Very Early Onset Schizophrenia'. Together they form a unique fingerprint.

Cite this